Relation between medial temporal atrophy and functional brain activity during memory processing in Alzheimer's disease: A combined MRI and SPECT study

Journal of Neurology Neurosurgery and Psychiatry

Volumn 73, Issue 5, 2002, Pages 508-516

  Garrido, G E J ^a   Busatto, G F ^a   Furuie, S S ^a   Buchpiguel, C A ^a   Bottino, C M C ^a   Almeida, O P ^b   Cid, C G ^a   Camargo, C H P ^a   Castro, C C ^a   Glabus, M F ^c  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN ATROPHY; BRAIN BLOOD FLOW; BRAIN FUNCTION; BRAIN MAPPING; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FRONTAL LOBE; GRAY MATTER; HIPPOCAMPUS; HUMAN; LIMBIC CORTEX; MALE; MEMORY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TEMPORAL CORTEX; WORD RECOGNITION;

ALZHEIMER DISEASE; ATROPHY; BRAIN; CEREBROVASCULAR CIRCULATION; FEMALE; HIPPOCAMPUS; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MEMORY DISORDERS; NEUROPSYCHOLOGICAL TESTS; SEVERITY OF ILLNESS INDEX; SEX FACTORS; TEMPORAL LOBE; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0036828751     PISSN: 00223050     EISSN: None     Source Type: Journal    
DOI: 10.1136/jnnp.73.5.508     Document Type: Article

References (56)

1. Terry RD, Katzman R. Senile dementia of the Alzheimer type. Ann Neurol 1983;14:497-506.
2. Braak H, Braak E. Neuropathological staging of Alzheimer-related changes. Acta Neuropathol (Berl) 1991;82:239-59.
3. Arriagada PV, Growdon JH, Hedley-Whyte ET, et al. Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease. Neurology 1992;42:631-9.
4. Squire LR, Zola-Morgan S. The medial temporal lobe memory system. Science 1991;253:1380-6.
5. O'Brien JT. Is hippocampal atrophy on magnetic resonance imaging a marker for Alzheimer's disease? Int J Geriatr Psychiatry 1995;10:431-5.
6. Laakso MP, Soininen H, Partanen K, et al. Volumes of hippocampus, amygdala and frontal lobes in the MRI-based diagnosis of early Alzheimer's disease: Correlation with memory functions. J Neural Transm Park Dis Dement Sect 1995;9:73-86.
7. Jack CR, Petersen RC, Xu YC, et al. Medial temporal atrophy on MRI in normal aging and very mild Alzheimer's disease. Neurology 1997;49:786-94.
8. Pantel J, Schroder J, Schad LR, et al. Quantitative magnetic resonance imaging and neuropsychological functions in dementia of the Alzheimer type. Psychol Med 1997;27:221-9.
9. Krasuski JS, Alexander GE, Horwitz B, et al. Volumes of medial temporal lobe structures in patients with Alzheimer's disease and mild cognitive impairment (and in healthy controls). Biol Psychiatry 1998;43:60-8.
10. Petersen RC, Jack CR, Xu YC, et al. Memory and MRI-based hippocampal volumes in aging and AD. Neurology 2000;54:581-7.
11. Gemmell HG, Sharp PF, Besson JA, et al. Differential diagnosis in dementia using the cerebral blood flow agent 99mTc HM-PAO: A SPECT study. J Comput Assist Tomogr 1987;11:398-402.
12. Costa DC, Ell PJ, Burns A, et al. CBF tomograms with [99mTc]-HM-PAO in patients with dementia (Alzheimer type and HIV) and Parkinson's disease - Initial results. J Cereb Blood Flow Metab 1988;8:S109-15.
13. Rapoport SI, Horwitz B, Grady CL, et al. Abnormal brain glucose metabolism in Alzheimer's disease, as measured by position emission tomography. Adv Exp Med Biol 1991;291:231-48.
14. Holman BL, Johnson KA, Gerada B, et al. The scintigraphic appearance of Alzheimer's disease: A prospective study using technetium-99m-HMPAO SPECT. J Nucl Med 1992;33:181-5.
15. Ohnishi T, Hoshi H, Nagamachi S, et al. High-resolution SPECT to assess hippocampal perfusion in neuropsychiatric diseases. J Nucl Med 1995;36:1163-9.
16. Kogure D, Matsuda H, Ohnishi T, et al. Longitudinal evaluation of early Alzheimer's disease using brain perfusion SPECT. J Nucl Med 2000;41:1155-62.
17. Matsuda H. Cerebral blood flow and metabolic abnormalities in Alzheimer's disease. Ann Nucl Med 2001;15:85-92.
18. Riddle W, O'Carroll RE, Dougall N, et al. A single photon emission computerised tomography study of regional brain function underlying verbal memory in patients with Alzheimer-type dementia. Br J Psychiatry 1993;163:166-72.
19. Becker JT, Mintun MA, Aleva K, et al. Compensatory reallocation of brain resources supporting verbal episodic memory in Alzheimer's disease. Neurology 1996;46:692-700.
20. Woodard JL, Grafton ST, Votaw JR, et al. Compensatory recruitment of neural resources during overt rehearsal of word lists in Alzheimer's disease. Neuropsychology 1998;12:491-504.
21. Cardebat D, Demonet JF, Puel M, et al. Brain correlates of memory processes in patients with dementia of Alzheimer's type: A SPECT activation study. J Cereb Blood Flow Metab 1998;18:457-62.
22. Saykin AJ, Flashman LA, Frutiger SA, et al. Neuroanatomic substrates of semantic memory impairment in Alzheimer's disease: Patterns of functional MRI activation. J Int Neuropsychol Soc 1999;5:377-92.
23. Backman L, Andersson JL, Nyberg L, et al. Brain regions associated with episodic retrieval in normal aging and Alzheimer's disease. Neurology 1999;52:1861-70.
24. Grady CL, Furey ML, Pietrini P, et al. Altered brain functional connectivity and impaired short-term memory in Alzheimer's disease. Brain 2001;124:739-56.
25. Cabeza R, Nyberg L. Imaging cognition II: An empirical review of 275 PET and fMRI studies. J Cogn Neurosci 2000;12:1-47.
26. Rapoport SI. In vivo PET imaging and postmortem studies suggest potentially reversible and irreversible stages of brain metabolic failure in Alzheimer's disease. Eur Arch Psychiatry Clin Neurosci 1999;249:46-55.
27. Jobst KA, Smith AD, Barker CS, et al. Association of atrophy of the medial temporal lobe with reduced blood flow in the posterior parietotemporal cortex in patients with a clinical and pathological diagnosis of Alzheimer's disease. J Neurol Neurosurg Psychiatry 1992;55:190-4.
28. Yamaguchi S, Meguro K, Itoh M, et al. Decreased cortical glucose metabolism correlates with hippocampal atrophy in Alzheimer's disease as shown by MRI and PET. J Neurol Neurosurg Psychiatry 1997;62:596-600.
29. Meguro K, LeMestric C, Landeau B, et al. Relations between hypometabolism in the posterior association neocortex and hippocampal atrophy in Alzheimer's disease: A PET/MRI correlative study. J Neurol Neurosurg Psychiatry 2001;71:315-21.
30. McKhann G, Drachman D, Folstein M, et al. Clinical diagnosis of Alzheimer's disease: Report of NINCDS/ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 1984;34:939-44.
31. Roth M, Tym E, Mountjoy CQ, et al. CAMDEX. A standardised instrument for the diagnosis of mental disorder in the elderly with special reference to the early detection of dementia. Br J Psychiatry 1986;149:698-709.
32. Folstein MF, Folstein SE, McHugh PR. Mini mental state: A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-98.
33. Associação Brasileira de Anunciantes. XXXI Estudos Marplan. São Paulo: Marplan Brasil Representações e Pesquisas Ltda, 1989.
34. Monsch AU, Bondi MW, Butters N, et al. Comparisons of verbal fluency tasks in the detection of dementia of the Alzheimer type. Arch Neurol 1992;49:1253-8.
35. Fuld PA, Masur DM, Blau AD, et al. Object-memory evaluation for prospective detection of dementia in normal functioning elderly: Predictive and normative data. J Clin Exp Neuropsychol 1990;12:520-8.
36. Ashburner J, Friston KJ. Voxel-based morphometry - The methods. Neuroimage 2000;11:805-21.
37. Talairach J, Tornoux P. Co-Planar Stereotoxic Atlas of the Human Brain. New York: Thieme, 1988.
38. Busatto GF, Costa DC, Ell PJ, et al. Regional cerebral blood flow (rCBF) in schizophrenia during verbal memory activation: A 99mTc-HMPAO single photon emission tomography (SPET) study. Psychol Med 1994;24:463-72.
39. 99mTc-d,I-HMPAO compared to xenon-133. J Cereb Blood Flow Metab 1988;8:S69-81.
40. Friston KJ, Holmes AP, Worsley KJ, et al. Statistical parametric maps in functional imaging: A general linear approach. Hum Brain Mapping 1995;2:189-210.
41. Friston KJ, Holmes A, Poline JB, et al. Detecting activations in PET and fMRI: Levels of inference and power. Neuroimage 1996;4:223-35.
42. Busatto GF, Garrido GE, Almeida OP, et al. A voxel-based morphometry study of temporal lobe grey matter reductions in Alzheimer's disease. Neurobiol Aging 2002 (in press).
43. Rombouts SA, Barkhof F, Witter MP, et al. Unbiased whole-brain analysis of gray matter loss in Alzheimer's disease. Neurosci Lett 2000;285:231-3.
44. Baron JC, Chetelat G, Desgranges B, et al. In vivo mapping of gray matter loss with voxel-based morphometry in mild Alzheimer's disease. Neuroimage 2001;14:298-309.
45. Kessler J, Herholz K, Grond M, et al. Impaired metabolic activation in Alzheimer's disease: A PET study during continuous visual recognition. Neuropsychologia 1991;29:229-43.
46. Meltzer CC, Zubieta JK, Brandt J, et al. Regional hypometabolism in Alzheimer's disease as measured by positron emission tomography after correction for effects of partial volume averaging. Neurology 1996;47:454-61.
47. Small GW, Ercoli LM, Silverman DH, et al. Cerebral metabolic and cognitive decline in persons at genetic risk for Alzheimer's disease. Proc Natl Acad Sci USA 2000;97:6037-42.
48. Pandya DN, Van Hoesen GW, Mesulam MM. Efferent connections of the cingulate gyrus in the rhesus monkey. Exp Brain Res 1981;42:319-30.
49. Desgranges B, Baron JC, de la Sayette V, et al. The neural substrates of memory systems impairment in Alzheimer's disease. A PET study of resting brain glucose utilization. Brain 1998;121:611-31.
50. Furey ML, Pietrini P, Haxby JV, et al. Cholinergic stimulation alters performance and task-specific regional cerebral blood flow during working memory. Proc Natl Acad Sci USA 1997;94:6512-6.
51. Nakano S, Asada T, Matsuda H, et al. Donepezil hydrochloride preserves regional cerebral blood flow in patients with Alzheimer's disease. J Nucl Med 2001;42:1441-5.
52. Potkin SG, Anand R, Fleming K, et al. Brain metabolic and clinical effects of rivastigmine in Alzheimer's disease. Int J Neuropsychopharmacol 2001;4:223-30.
53. McDermott KB, Jones TC, Petersen SE, et al. Retrieval success is accompanied by enhanced activation in anterior prefrontal cortex during recognition memory: An event-related fMRI study. J Cogn Neurosci 2000;12:965-76.
54. Donaldson DI, Petersen SE, Ollinger JM, et al. Dissociating state and item components of recognition memory using fMRI. Neuroimage 2001;13:129-42.
55. Daselaar SM, Rombouts SA, Veltman DJ, et al. Parahippocampal activation during successful recognition of words: A self-paced event-related fMRI study. Neuroimage 2001;13:1113-20.
56. Montgomery AS, Åsberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry 1979;134:382-9.